62nd Annual Meeting

October 26 - 31, 2015

Clinical Consultation Breakfast 17 (sold out)

Master Clinician: Moira A. Rynn, MD: Present Treatment for Anxiety Disorders and New Directions

Dr. Moira Rynn is the Ruane Professor for the Implementation of Science for Child and Adolescent Mental Health (in Psychiatry) at the College of Physician and Surgeons of Columbia University (CU) and the Director of the Child and Adolescent Psychiatric Division at Morgan Stanley Children’s Hospital at New York Presbyterian and also at New York State Psychiatric Institute. She is the Medical Director of The Columbia University Clinic for Anxiety and Related Disorders (CUCARD) and Unit Chief of the Children’s Day Unit. She was recruited by the Division of Child and Adolescent Psychiatry in 2006, as an established, expert pediatric psychopharmacologist, and appointed Deputy Director of Research. Dr. Rynn’s research program studies improving treatments for children and adolescents with treatment refractory anxiety disorders.  Her research examines the efficacy and safety of experimental pharmacologic treatments as well as studying combination treatment (medication and psychotherapy) approaches in the pediatric population. She has led and contributed to the seminal treatment trials in the field of pediatric anxiety.  More recently, through her collaborations, she is examining treatment models for adolescent depression in the primary care setting as well as novel augmentation strategies for pediatric OCD.  Her programs have received funding from the National Institute of Mental Health and the National Institute of Child and Health Development. Dr. Rynn discusses the development of new treatments for pediatric anxiety disorders and reviews the impact of parental anxiety and accommodation on the outcome of anxiety treatment.